Christopher D. Watt

2.5k total citations
25 papers, 456 citations indexed

About

Christopher D. Watt is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Christopher D. Watt has authored 25 papers receiving a total of 456 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 7 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in Christopher D. Watt's work include Cancer Genomics and Diagnostics (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Acute Myeloid Leukemia Research (4 papers). Christopher D. Watt is often cited by papers focused on Cancer Genomics and Diagnostics (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Acute Myeloid Leukemia Research (4 papers). Christopher D. Watt collaborates with scholars based in United States, Australia and Israel. Christopher D. Watt's co-authors include Jaimo Ahn, Siri Atma W. Greeley, Corey J. Langer, Tracey L. Evans, Judy A. Shea, Charu Aggarwal, Anil Vachani, Rosemarie Mick, Joshua Bauml and Yu Zhang and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Christopher D. Watt

24 papers receiving 444 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher D. Watt United States 12 140 131 119 106 99 25 456
R Ueda Japan 9 118 0.8× 103 0.8× 43 0.4× 107 1.0× 47 0.5× 23 380
Matthew Hiemenz United States 12 155 1.1× 179 1.4× 58 0.5× 75 0.7× 54 0.5× 43 448
Sadashivudu Gundeti India 11 91 0.7× 109 0.8× 101 0.8× 67 0.6× 131 1.3× 69 381
Y.S. Chae South Korea 11 121 0.9× 194 1.5× 47 0.4× 120 1.1× 120 1.2× 41 412
Anthea Lau Canada 9 154 1.1× 158 1.2× 29 0.2× 57 0.5× 93 0.9× 28 413
Satyajit Kosuri United States 12 50 0.4× 150 1.1× 73 0.6× 128 1.2× 247 2.5× 47 420
Glicksman As United States 8 106 0.8× 110 0.8× 158 1.3× 65 0.6× 98 1.0× 13 435
S. Giralt United States 5 50 0.4× 218 1.7× 75 0.6× 57 0.5× 325 3.3× 18 486
Clara Lam United States 8 51 0.4× 127 1.0× 38 0.3× 42 0.4× 55 0.6× 20 339
Benjamin M. Parsons United States 12 90 0.6× 204 1.6× 37 0.3× 59 0.6× 34 0.3× 36 440

Countries citing papers authored by Christopher D. Watt

Since Specialization
Citations

This map shows the geographic impact of Christopher D. Watt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher D. Watt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher D. Watt more than expected).

Fields of papers citing papers by Christopher D. Watt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher D. Watt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher D. Watt. The network helps show where Christopher D. Watt may publish in the future.

Co-authorship network of co-authors of Christopher D. Watt

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher D. Watt. A scholar is included among the top collaborators of Christopher D. Watt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher D. Watt. Christopher D. Watt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Burghel, George J., Jamie M. Ellingford, Ronnie Wright, et al.. (2024). Systematic reanalysis of copy number losses of uncertain clinical significance. Journal of Medical Genetics. 61(7). 621–625.
2.
Nasrallah, MacLean P., Zev A. Binder, Derek A. Oldridge, et al.. (2019). Molecular Neuropathology in Practice: Clinical Profiling and Integrative Analysis of Molecular Alterations in Glioblastoma. Academic Pathology. 6. 1533848481–1533848481. 16 indexed citations
3.
Brown, Justin T., Walairat Laosinchai-Wolf, Marie E. Fahey, et al.. (2019). Analytical Validation of a Highly Sensitive, Multiplexed Chronic Myeloid Leukemia Monitoring System Targeting BCR-ABL1 RNA. Journal of Molecular Diagnostics. 21(4). 718–733. 9 indexed citations
4.
Rathore, Saima, Spyridon Bakas, MacLean P. Nasrallah, et al.. (2018). Non-invasive determination of the O6-methylguanine-DNA-methyltransferase (MGMT) promoter methylation status in glioblastoma (GBM) using magnetic resonance imaging (MRI).. Journal of Clinical Oncology. 36(15_suppl). 2051–2051. 5 indexed citations
5.
Watt, Christopher D., Jennifer J.D. Morrissette, Adam I. Rubin, et al.. (2016). Marginal zone lymphoma-derived interfollicular diffuse large B-cell lymphoma harboring 20q12 chromosomal deletion and missense mutation of BIRC3 gene: a case report. Diagnostic Pathology. 11(1). 137–137. 6 indexed citations
6.
Hiemenz, Matthew, Stephan Kadauke, David Lieberman, et al.. (2016). Building a Robust Tumor Profiling Program: Synergy between Next-Generation Sequencing and Targeted Single-Gene Testing. PLoS ONE. 11(4). e0152851–e0152851. 6 indexed citations
7.
Aggarwal, Charu, William Y. Shi, Christopher D. Watt, et al.. (2014). Ectopic Hypercellular Parathyroid Tissue of the Mediastinum Masquerading As Metastatic Adenocarcinoma on Positron Emission Tomography–Computed Tomography Scan. Journal of Clinical Oncology. 32(30). e101–e103. 1 indexed citations
8.
Bauml, Joshua, Rosemarie Mick, Yu Zhang, et al.. (2013). Determinants of Survival in Advanced Non–Small-Cell Lung Cancer in the Era of Targeted Therapies. Clinical Lung Cancer. 14(5). 581–591. 37 indexed citations
9.
Frank, Renee, Zubair Baloch, Caren Gentile, Christopher D. Watt, & Virginia A. LiVolsi. (2013). Multifocal Fibrosing Thyroiditis and Its Association with Papillary Thyroid Carcinoma Using BRAF Pyrosequencing. Endocrine Pathology. 25(3). 236–240. 9 indexed citations
10.
Bauml, Joshua, Rosemarie Mick, Yu Zhang, et al.. (2013). Frequency of EGFR and KRAS mutations in patients with non small cell lung cancer by racial background: Do disparities exist?. Lung Cancer. 81(3). 347–353. 71 indexed citations
11.
Nybakken, Grant E., Christopher D. Watt, Jennifer J.D. Morrissette, et al.. (2012). Diverse Histopathologic and Molecular Responses of Acute Myeloid Leukemia to the FLT3 Inhibitor Quizartinib (AC220). Blood. 120(21). 885–885. 1 indexed citations
12.
Sohal, Davendra, Ursina Teitelbaum, Takeshi Uehara, et al.. (2012). A phase II trial of gemcitabine, irinotecan, and panitumumab in advanced cholangiocarcinoma, with correlative analysis of EGFR, KRAS, and BRAF: An interim report.. Journal of Clinical Oncology. 30(15_suppl). 4111–4111. 1 indexed citations
13.
King, Rebecca L., Mojdeh Naghashpour, Christopher D. Watt, Jennifer J.D. Morrissette, & Adam Bagg. (2011). A Comparative Analysis of Molecular Genetic and Conventional Cytogenetic Detection of Diagnostically Important Translocations in More Than 400 Cases of Acute Leukemia, Highlighting the Frequency of False-Negative Conventional Cytogenetics. American Journal of Clinical Pathology. 135(6). 921–928. 20 indexed citations
14.
Aisner, Dara L., Charuhas Deshpande, Zubair Baloch, et al.. (2011). Evaluation of EGFR mutation status in cytology specimens: An institutional experience. Diagnostic Cytopathology. 41(4). 316–323. 53 indexed citations
15.
Watt, Christopher D. & Adam Bagg. (2010). Molecular diagnosis of acute myeloid leukemia. Expert Review of Molecular Diagnostics. 10(8). 993–1012. 11 indexed citations
16.
Bajaj, Navkaranbir S., Christopher D. Watt, Denis Hadjiliadis, et al.. (2010). Donor transmission of malignant melanoma in a lung transplant recipient 32 years after curative resection. Transplant International. 23(7). e26–e31. 19 indexed citations
17.
Yamamoto, Masakazu, et al.. (2007). Cloning and characterization of a novel MyoD enhancer-binding factor. Mechanisms of Development. 124(9-10). 715–728. 10 indexed citations
18.
Ahn, Jaimo, Christopher D. Watt, Li‐Xing Man, Siri Atma W. Greeley, & Judy A. Shea. (2007). Educating Future Leaders of Medical Research: Analysis of Student Opinions and Goals from the MD???PhD SAGE (Students??? Attitudes, Goals, and Education) Survey. Academic Medicine. 82(7). 633–645. 37 indexed citations
19.
Watt, Christopher D., Siri Atma W. Greeley, Judy A. Shea, & Jaimo Ahn. (2005). Educational Views and Attitudes, and Career Goals of MD???PhD Students at the University of Pennsylvania School of Medicine. Academic Medicine. 80(2). 193–198. 31 indexed citations
20.
Ahn, Jaimo, Christopher D. Watt, Siri Atma W. Greeley, & Joseph Bernstein. (2004). MD-PhD Students in a Major Training Program Show Strong Interest in Becoming Surgeon-Scientists. Clinical Orthopaedics and Related Research. 425(425). 258–263. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026